KIM
JSPR icon

Karpus Investment Management’s Jasper Therapeutics JSPR Stock Holding History

Karpus Investment Management’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-43,076
Closed -$4.28M – 308
2021
Q2 		$4.28M Buy
43,076
+3,092
+8% +$307K 0.13% 147
2021
Q1 		$3.96M Buy
39,984
+31,279
+359% +$3.18M 0.12% 141
2020
Q4 		$871K Sell
8,705
-4,400
-34% -$438K 0.03% 181
2020
Q3 		$1.3M Sell
13,105
-160
-1% -$16K 0.05% 150
2020
Q2 		$1.33M Hold
13,265
– – 0.05% 142
2020
Q1 		$1.27M Buy
+13,265
New +$1.3M 0.05% 152

Other funds holding JSPR

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPARFS
Leverage Partners Absolute Return Fund SPC Cayman Islands Ky1-11111, Cayman Islands $78M AUM 2.19% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return